Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized International Multicenter Study to Compare Short Versus Long Adjuvant Immunotherapy After Radical Surgery of Stage IIb-c, III and IV Cutaneous Malignant Melanoma (Grand SLAM)

NCT06488482 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT06488482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06488482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized International Multicenter Study to Compare Short Versus Long Adjuvant Immunotherapy After Radical Surgery of Stage IIb-c, III and IV Cutaneous Malignant Melanoma (Grand SLAM)
Lead sponsor
Uppsala University
Phase
Phase 3
Overall status
Recruiting
Start date
December 19, 2024
Completion date
September 30, 2033
Enrollment
1,792 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk melanoma